Target Name: Acid-Sensing Ion Channel (ASIC)
NCBI ID: P13067
Review Report on Acid-Sensing Ion Channel (ASIC) Target / Biomarker Content of Review Report on Acid-Sensing Ion Channel (ASIC) Target / Biomarker
Acid-Sensing Ion Channel (ASIC)
Other Name(s): Amiloride-Sensitive Cation Channel | ASIC | ACCN

ASIC: A Potential Drug Target and Biomarker

The Acid-Sensing Ion Channel (ASIC) is a transmembrane protein that plays a crucial role in cell signaling and has been identified as a potential drug target or biomarker. It is a nonspecific cation channel that is sensitive to amiloride, a common drug used to treat hypertension. This protein is found in many different cell types, including neurons, cardiac muscle, and epithelial cells.

ASIC is made up of four subunits that are held together by ionic bonds. It has a unique structure that allows it to detect changes in the concentration of ions in the surrounding environment. When an ion is present in high concentration, the channel is closed, and when it is absent, the channel is open. This allows the cell to regulate the flow of ions in and out of the cell, which can have a significant impact on the cell's behavior.

ASIC has been shown to be involved in many different signaling pathways. For example, it has been shown to be involved in neurotransmitter signaling, where it is thought to play a role in the transmission of signals from the brain to the rest of the body. It has also been shown to be involved in the regulation of ion channels in the heart, where it is thought to play a role in the control of heart rate and contractions.

ASIC has also been shown to be a potential drug target. The high concentration of amiloride that is required to activate ASIC makes it an attractive target for drug development. Amiloride is a commonly used drug for hypertension and has been shown to be an effective treatment for this condition. However, the high concentration of amiloride required to activate ASIC makes it difficult to use as a drug.

In addition to its potential use as a drug target, ASIC has also been shown to be a potential biomarker. The regulation of ASIC activity has been shown to be involved in many different diseases, including hypertension, heart disease, and neurodegenerative diseases. This makes it an attractive target for the development of new diagnostic tools and therapies.

In conclusion, the Acid-Sensing Ion Channel (ASIC) is a transmembrane protein that plays a crucial role in cell signaling and has been identified as a potential drug target or biomarker. Its unique structure and involvement in many different signaling pathways make it an attractive target for drug development. Further research is needed to fully understand the role of ASIC in disease and to develop new treatments.

Protein Name: Acid-Sensing Ion Channel (ASIC) (nonspecified Subtype)

The "Acid-Sensing Ion Channel (ASIC) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Acid-Sensing Ion Channel (ASIC) comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ACIN1 | ACKR1 | ACKR2 | ACKR3 | ACKR4 | ACKR4P1 | ACLY | ACMSD | ACO1 | ACO2 | ACOD1 | ACOT1 | ACOT11 | ACOT12 | ACOT13 | ACOT2 | ACOT4 | ACOT6 | ACOT7 | ACOT8 | ACOT9 | ACOX1 | ACOX2 | ACOX3 | ACOXL | ACOXL-AS1 | ACP1 | ACP2 | ACP3 | ACP4 | ACP5 | ACP6 | ACP7 | ACR | ACRBP | ACRV1 | ACSBG1 | ACSBG2 | ACSF2 | ACSF3 | ACSL1 | ACSL3 | ACSL4 | ACSL5 | ACSL6 | ACSM1 | ACSM2A | ACSM2B | ACSM3 | ACSM4 | ACSM5 | ACSM6 | ACSS1 | ACSS2 | ACSS3 | ACTA1 | ACTA2 | ACTA2-AS1 | ACTB | ACTBL2 | ACTBP12 | ACTBP2 | ACTBP3 | ACTBP8 | ACTBP9 | ACTC1 | ACTE1P | ACTG1 | ACTG1P1 | ACTG1P10 | ACTG1P12 | ACTG1P17 | ACTG1P20 | ACTG1P22 | ACTG1P25 | ACTG1P4 | ACTG2 | Actin | Activating signal cointegrator 1 complex protein | Activin receptor type 2 (nonspecifed subtype) | ACTL10 | ACTL6A | ACTL6B | ACTL7A | ACTL7B | ACTL8 | ACTL9 | ACTMAP | ACTN1 | ACTN1-DT | ACTN2 | ACTN3 | ACTN4 | ACTR10 | ACTR1A | ACTR1B | ACTR2 | ACTR3 | ACTR3B | ACTR3BP2